BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saia-cereda VM, Cassoli JS, Schmitt A, Falkai P, Martins-de-souza D. Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients. Schizophrenia Research 2016;177:70-7. [DOI: 10.1016/j.schres.2016.03.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira FAA, Buri MV, Rodriguez BL, Costa-da-Silva AL, Araújo HRC, Capurro ML, Lu S, Tanaka AS. The first characterization of a cystatin and a cathepsin L-like peptidase from Aedes aegypti and their possible role in DENV infection by the modulation of apoptosis. Int J Biol Macromol 2020;146:141-9. [PMID: 31857170 DOI: 10.1016/j.ijbiomac.2019.12.010] [Reference Citation Analysis]
2 Nascimento JM, Garcia S, Saia-cereda VM, Santana AG, Brandao-teles C, Zuccoli GS, Junqueira DG, Reis-de-oliveira G, Baldasso PA, Cassoli JS, Martins-de-souza D. Proteomics and molecular tools for unveiling missing links in the biochemical understanding of schizophrenia. Prot Clin Appl 2016;10:1148-58. [DOI: 10.1002/prca.201600021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
3 Antunes ASLM, de Almeida V, Crunfli F, Carregari VC, Martins-de-Souza D. Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders. Adv Exp Med Biol 2021;1286:251-64. [PMID: 33725358 DOI: 10.1007/978-3-030-55035-6_17] [Reference Citation Analysis]
4 Fioramonte M, Guest PC, Martins-de-Souza D. LC-MSE for Qualitative and Quantitative Proteomic Studies of Psychiatric Disorders. Adv Exp Med Biol 2017;974:115-29. [PMID: 28353228 DOI: 10.1007/978-3-319-52479-5_7] [Reference Citation Analysis]
5 Reis-de-Oliveira G, Zuccoli GS, Fioramonte M, Schimitt A, Falkai P, Almeida V, Martins-de-Souza D. Digging deeper in the proteome of different regions from schizophrenia brains. J Proteomics 2020;223:103814. [PMID: 32389842 DOI: 10.1016/j.jprot.2020.103814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
6 Zuccoli GS, Saia-Cereda VM, Nascimento JM, Martins-de-Souza D. The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence. Front Neurosci 2017;11:493. [PMID: 28936160 DOI: 10.3389/fnins.2017.00493] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 12.2] [Reference Citation Analysis]
7 Giusti L, Ciregia F, Mazzoni MR, Lucacchini A. Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers. Expert Review of Proteomics 2016;13:941-50. [DOI: 10.1080/14789450.2016.1230499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Li T, Lee M, Tsai F, Chen Y, Lin Y, Chen M. Proteomic study revealed antipsychotics-induced nuclear protein regulations in B35 cells are similar to the regulations in C6 cells and rat cortex. BMC Pharmacol Toxicol 2018;19:9. [PMID: 29514709 DOI: 10.1186/s40360-018-0199-0] [Reference Citation Analysis]
9 Saia-Cereda VM, Santana AG, Schmitt A, Falkai P, Martins-de-Souza D. The Nuclear Proteome of White and Gray Matter from Schizophrenia Postmortem Brains. Mol Neuropsychiatry 2017;3:37-52. [PMID: 28879200 DOI: 10.1159/000477299] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
10 Velásquez E, Nogueira FCS, Velásquez I, Schmitt A, Falkai P, Domont GB, Martins-de-Souza D. Synaptosomal Proteome of the Orbitofrontal Cortex from Schizophrenia Patients Using Quantitative Label-Free and iTRAQ-Based Shotgun Proteomics. J Proteome Res 2017;16:4481-94. [PMID: 28949146 DOI: 10.1021/acs.jproteome.7b00422] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
11 Sun ZY, Gu HS, Chen X, Zhang L, Li XM, Zhang JW, Li L. A novel flavanone derivative ameliorates cuprizone-induced behavioral changes and white matter pathology in the brain of mice. Psychiatry Res 2017;257:249-59. [PMID: 28783571 DOI: 10.1016/j.psychres.2017.07.075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
12 Williams MR, Sharma P, Macdonald C, Pearce RKB, Hirsch SR, Maier M. Axonal myelin decrease in the splenium in major depressive disorder. Eur Arch Psychiatry Clin Neurosci 2019;269:387-95. [PMID: 29980921 DOI: 10.1007/s00406-018-0904-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
13 Illescas O, Pacheco-Fernández T, Laclette JP, Rodriguez T, Rodriguez-Sosa M. Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system. Cytokine 2020;133:155121. [PMID: 32417648 DOI: 10.1016/j.cyto.2020.155121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Borgmann-Winter KE, Wang K, Bandyopadhyay S, Torshizi AD, Blair IA, Hahn CG. The proteome and its dynamics: A missing piece for integrative multi-omics in schizophrenia. Schizophr Res 2020;217:148-61. [PMID: 31416743 DOI: 10.1016/j.schres.2019.07.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]